That is a good question. I had thought that some knowledgeable posters here had opined that it might be due this Spring sometime. Once we hear that Amarin has been granted the patent, we need our tight lipped management to clue us in to how they will proceed with it and what that all involves. No question that it would at a very minimum offer us at least some additional way to try to get around the Generics assuming they still have their hold on V.
Looking forward to others reading your question and providing a more informed answer.
Market Data 
Markets 
AI
